AIIMS director Dr Randeep Guleria has said vaccination is the way out of the coronavirus pandemic as he gave a timeline for the availability of jabs for children against Covid-19, which so far has not affected them in a big way. Dr Guleria acknowledged that children have lost on learning out as schools have remained closed in the last one-and-half years because of the pandemic. “Schools have to be reopened and vaccination can play an important role in that,” the senior doctor was quoted as saying by news agency PTI.
Children Get vaccine around September
The chief of India’s premier All India Institute of Medical Sciences said that making the Covid-19 vaccine available for children will be a milestone achievement and pave the way for the reopening of schools and resumption of outdoor activities for them. Dr Guleria also said vaccines could be available for children in India around September when data from Phase 2 and 3 trials of Bharat Biotech’s Covaxin on those in the age group of 2 to 18 years is expected. The Covid-19 vaccine could be given to children after the Drugs Controller General of India’s (DCGI’s) approval, Dr Guleria said. “If the Pfizer vaccine gets approval before that, then it can also be an option for children,” Dr Guleria told PTI on Saturday.
Children Need to be Procure by Third Wave
Several experts have said that children will be affected the most in a possible third wave of the pandemic. A State Bank of India (SBI) research document has also said that children could be the most vulnerable group in the third wave, which could be as severe as the second and last for an average duration of 98 days. The impact of any possible third wave of the pandemic could be significantly minimised by rigorous vaccination and providing better health infrastructure.
However, the apprehension that children will be more affected or have greater illness severity in the possible third wave has been dismissed. The government has said that even though Covid-19 has not impacted children greatly so far but if the coronavirus’ behaviour changes or there are shifts in epidemiology dynamics, they are likely to be affected.